COVID-19 and Diabetes Mellitus: The Impact of Two Pandemics

Authors

  • Pedro Oliveira Serviço de Medicina Interna. Centro Hospitalar de Vila Nova de Gaia-Espinho. Vila Nova de Gaia. https://orcid.org/0000-0002-2893-6965
  • Joana Louro Serviço de Medicina Interna. Centro Hospitalar do Oeste. Caldas da Rainha.
  • Pedro Gil Serviço de Medicina Interna. Centro Hospitalar de Vila Nova de Gaia-Espinho. Vila Nova de Gaia.
  • Luís Andrade Serviço de Medicina Interna. Centro Hospitalar Entre Douro e Vouga. Santa Maria da Feira.

DOI:

https://doi.org/10.20344/amp.16758

Keywords:

COVID-19, Diabetes Mellitus, Hypoglycemic Agents, SARS-CoV-2

Abstract

N/a.

Downloads

Download data is not yet available.

References

Drucker DJ. Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications. Endocr Rev. 2020;41:bnaa011. DOI: https://doi.org/10.1210/endrev/bnaa011

Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020;8:782–92. DOI: https://doi.org/10.1016/S2213-8587(20)30238-2

Zanza C, Romenskaya T, Manetti AC, Franceschi F, La Russa R, Bertozzi G, et al. Cytokine storm in COVID-19: immunopathogenesis and therapy. Medicina. 2022;58:144. DOI: https://doi.org/10.3390/medicina58020144

Fadini GP, Morieri ML, Longato E, Avogaro A. Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrinol Invest. 2020;43:867-9. DOI: https://doi.org/10.1007/s40618-020-01236-2

Cariou B, Hadjadj S, Wargny M, Pichelin M, Al-Salameh A, Allix I, et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020;63:1500-15. DOI: https://doi.org/10.1007/s00125-020-05180-x

Rayman G, Lumb A, Kennon B, Cottrell C, Nagi D, Page E, et al. Guidance on the management of diabetic ketoacidosis in the exceptional circumstances of the COVID-19 pandemic. Diabet Med. 2020;37:1214-6. DOI: https://doi.org/10.1111/dme.14328

Hasan SS, Kow CS, Bain A, Kavanagh S, Merchant HA, Hadi MA. Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients. Expert Opin Pharmacother. 2021;22:229-40. DOI: https://doi.org/10.1080/14656566.2020.1837114

Pranata R, Henrina J, Raffaello WM, Lawrensia S, Huang I. Diabetes and COVID-19: the past, the present, and the future. Metabolism. 2021;121:154814. DOI: https://doi.org/10.1016/j.metabol.2021.154814

Published

2022-11-09

How to Cite

1.
Oliveira P, Louro J, Gil P, Andrade L. COVID-19 and Diabetes Mellitus: The Impact of Two Pandemics. Acta Med Port [Internet]. 2022 Nov. 9 [cited 2022 Dec. 7];35(12):925-6. Available from: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/16758

Issue

Section

Letters to the Editor